- Home
- MGRC vs SLNO Comparison
MGRC vs SLNO Comparison
Compare MGRC & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MGRC | SLNO |
|---|---|---|
| Founded | 1979 | 1999 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.3B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | MGRC | SLNO |
|---|---|---|
| Price | $115.68 | $38.49 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 10 |
| Target Price | ★ $141.50 | $112.70 |
| AVG Volume (30 Days) | 141.1K | ★ 1.4M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 1.66% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $5.46 | N/A |
| Revenue Next Year | $4.31 | $158.06 |
| P/E Ratio | $19.83 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $94.99 | $36.67 |
| 52 Week High | $129.93 | $90.32 |
Technical Indicators
Market Signals| Indicator | MGRC | SLNO |
|---|---|---|
| Relative Strength Index (RSI) | 52.82 | 39.60 |
| Support Level | $114.93 | $36.67 |
| Resistance Level | $118.25 | $41.84 |
| Average True Range (ATR) | 4.05 | 2.20 |
| MACD | -0.37 | -0.12 |
| Stochastic Oscillator | 45.83 | 22.03 |
Price Performance
Historical ComparisonAbout MGRC McGrath RentCorp
McGrath RentCorp is a rental company. It is comprised of four reportable business segments namely Modular building segment (Mobile Modular); Portable storage container segment (Portable Storage); Electronic test equipment segment (TRS-RenTelco); and its classroom manufacturing business selling modular buildings used as classrooms in California (Enviroplex). The company generates its revenues majorily from the rental of its equipment on operating leases with sales of equipment occurring in the normal course of business.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.